MetLife Investment Management’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.5M Sell
143,772
-4,987
-3% -$1.16M 0.15% 102
2025
Q4
$39.9M Sell
148,759
-5,835
-4% -$1.48M 0.19% 76
2025
Q3
$38.1M Sell
154,594
-4,920
-3% -$1.28M 0.18% 78
2025
Q2
$47.7M Sell
159,514
-2,983
-2% -$909K 0.28% 48
2025
Q1
$50.7M Sell
162,497
-2,940
-2% -$1.04M 0.27% 48
2024
Q4
$58.2M Buy
165,437
+2,537
+2% +$913K 0.32% 37
2024
Q3
$57.6M Sell
162,900
-4,783
-3% -$1.57M 0.33% 37
2024
Q2
$50.9M Sell
167,683
-5,357
-3% -$1.64M 0.3% 42
2024
Q1
$60M Sell
173,040
-5,447
-3% -$1.99M 0.4% 34
2023
Q4
$62.6M Buy
+178,487
New +$57.5M 0.45% 30
2023
Q3
Sell
-186,637
Closed -$57.6M 2890
2023
Q2
$57.6M Sell
186,637
-1,269
-0.7% -$369K 0.42% 32
2023
Q1
$53.7M Sell
187,906
-1,967
-1% -$536K 0.39% 33
2022
Q4
$50.7M Sell
189,873
-4,370
-2% -$1.21M 0.38% 35
2022
Q3
$50M Sell
194,243
-2,373
-1% -$686K 0.42% 32
2022
Q2
$54.6M Buy
196,616
+1,673
+0.9% +$503K 0.42% 34
2022
Q1
$65.7M Buy
194,943
+55,386
+40% +$18.7M 0.43% 33
2021
Q4
$57.9M Sell
139,557
-3,671
-3% -$1.34M 0.47% 29
2021
Q3
$45.8M Sell
143,228
-4,144
-3% -$1.35M 0.41% 36
2021
Q2
$43.4M Sell
147,372
-3,769
-2% -$1.08M 0.38% 44
2021
Q1
$41.8M Sell
151,141
-2,724
-2% -$704K 0.38% 42
2020
Q4
$40.2M Sell
153,865
-7,439
-5% -$1.78M 0.38% 44
2020
Q3
$36.5M Sell
161,304
-5,302
-3% -$1.21M 0.4% 44
2020
Q2
$35.8M Buy
166,606
+2,910
+2% +$550K 0.41% 43
2020
Q1
$26.7M Sell
163,696
-5,008
-3% -$965K 0.36% 52
2019
Q4
$35.5M Sell
168,704
-4,686
-3% -$913K 0.37% 45
2019
Q3
$33.4M Sell
173,390
-2,422
-1% -$469K 0.37% 44
2019
Q2
$32.5M Sell
175,812
-5,399
-3% -$970K 0.35% 49
2019
Q1
$31.9M Sell
181,211
-1,096
-0.6% -$172K 0.35% 53
2018
Q4
$25.7M Sell
182,307
-4,093
-2% -$648K 0.31% 61
2018
Q3
$31.7M Sell
186,400
-2,910
-2% -$484K 0.32% 53
2018
Q2
$31M Buy
189,310
+3,730
+2% +$580K 0.37% 48
2018
Q1
$28.5M Sell
185,580
-5,630
-3% -$892K 0.34% 52
2017
Q4
$29.3M Buy
+191,210
New +$27.7M 0.33% 48

Other funds holding ACN

MetLife Investment Management's ACN Position: Q1 2026 in Review

MetLife Investment Management reduced its Accenture (ACN) stake by 3.4% in Q1 2026, selling an estimated $1.16M and leaving 143,772 shares worth $28.5M. The position accounts for 0.15% of the portfolio, ranked #102.

MetLife Investment Management first reported a position in ACN in Q4 2017 and has held it in 33 quarters since. The position peaked at $65.7M in Q1 2022. 2,150 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • MetLife Investment Management held 143,772 shares of Accenture worth $28.5M as of Q1 2026.
  • MetLife Investment Management sold 4,987 Accenture shares in Q1 2026, an estimated $1.16M.
  • Accenture made up 0.15% of MetLife Investment Management's portfolio in Q1 2026, its #102 holding.
  • MetLife Investment Management first reported a position in Accenture in Q4 2017 and has held it in 33 quarters since.
  • MetLife Investment Management's Accenture position peaked at $65.7M in Q1 2022.
  • 2,150 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.